Skip to main content
Clinical Trials/ISRCTN81170837
ISRCTN81170837
Completed
Not Applicable

A double-blind, randomised, controlled multicentre trial of three misoprostol regimens after pretreatment with mifepristone for termination of early pregnancy

DP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction (HRP)0 sites2,100 target enrollmentApril 1, 2004

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pregnancy and Childbirth
Sponsor
DP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction (HRP)
Enrollment
2100
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2004
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
DP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction (HRP)

Eligibility Criteria

Inclusion Criteria

  • 1\. Healthy women
  • 2\. Eligible for and requesting medical abortion
  • 3\. Prepared to terminate the pregnancy should the treatment fail

Exclusion Criteria

  • No exclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A double-blind, randomised, controlled multicentre trial of misoprostol treatment prior to Vacuum Aspiration for termination of early pregnancy
ISRCTN98284169DP/UNFPA/WHO/World Bank - Special Programme of Research, Development and Research Training in Human Reproduction4,984
Active, not recruiting
Not Applicable
A multicentre, double-blind, randomised controlled trial of sodium bicarbonate to prevent acute kidney injury in patients undergoing cardiopulmonary bypass surgery. - Sodium Bicarbonate StudyCardiac surgical patients in whom the use of cardiopulmonary bypass is planned and having at least one ore more of the following risk factors for post-operative acute kidney injury• Age = 70 years• Preoperative plasma creatinine >120 µmol/L• Heart failure (NYHA class III / IV)• Insulin dependent diabetes mellitus• Valve surgery (with or without coronary artery bypass graft surgery)• Redo cardiac surgery
EUCTR2007-002223-32-IECharité Universitaetsmedizin402
Completed
Not Applicable
A randomized, double-blind, controlled multicenter trial for availability of carbon dioxide insufflation during ERCP for reduction of postprocedure paipancreaticobiliary disease
JPRN-UMIN000003062Department of Gastroenterology, Hokkaido University Graduate School of Medicine100
Not yet recruiting
Phase 1
A multicenter, randomized controlled, double-blind and double simulated clinical evaluation of gandouling tablet in the treatment of Wilson's diseaseWilson's diasease
ITMCTR2100005333The First Affiliated Hospital of Anhui University of traditional Chinese Medicine
Recruiting
Phase 2
A multicenter randomized, controlled, double-blinded trial to evaluate efficacy and safety of bortezomib in patients with severe autoimmune encephalitisautoimmune encephalitisG04Encephalitis, myelitis and encephalomyelitis
DRKS00017497Friedrich-Schiller-Universität Jena50